Inventisbio Co., Ltd

This phase 2 clinical trial tested an experimental oral drug called D-2570 in 161 adults with moderate-to-severe plaque psoriasis. Participants were randomly assigned to one of three doses of D-2570 or a placebo for 12 weeks. The main goal was to see how many people achieved at l…

This early-stage study tested the safety and how the body handles a new drug called D-2570 in 100 healthy adults aged 18 to 45. Participants took either the drug or a placebo, and researchers measured side effects, vital signs, and drug levels in the blood. The goal was to gather…